Kelly Bilodeau from Pharma Voice - Journalist Profile

	Profile	Contacts	Recent Articles on Subject
1	Kelly Bilodeau Pharma Voice Mom, wife, freelance writer. writing		What are pharma’s next blockbusters? - 5 months ago Babson gets one step closer to delivering on Theranos-like blood testing - 5 months ago What’s being done to prepare for the next pandemic? - 5 months ago Oncology drugmakers seek the sweet spot between efficacy and tolerability - 5 months ago The digital therapeutics revolution is here. Will payers play ball? - 6 months ago The weight loss market looks unstoppable. How high could it go? - 6 months ago Octave Bioscience is navigating the Parkinson’s labyrinth with Michael J. Fox’s help - 6 months ago As alcohol-related deaths climb, new drugs could curb the urge to drink - 6 months ago Biohaven wants to muscle in on the Ozempic craze with a competing class of drugs - 6 months ago Can Sarepta’s Duchenne gene therapy still deliver on its promise? - 6 months ago Humans can’t shake the mosquito threat. Here’s what pharma has in the pipeline. - 6 months ago An at-home flu vaccine? If approved, it could open the door to more DIY options - 6 months ago Tools like ChatGPT can personalize clinical trials tech — if companies avoid the pitfalls - 7 months ago What’s next for COVID dark horse Novavax? - 7 months ago Patient groups have become a powerhouse in R&D. Here’s a look at their impact. - 7 months ago An ‘inverse vaccine’ takes aim at autoimmune diseases - 7 months ago From the rainforest to Wall Street — Jaguar Health’s big play for revitalization - 7 months ago Has the science of anti-aging caught up with the dream of a longer life? - 7 months ago The ALS therapy keeping the human pig heart transplant pumping - 8 months ago Elderly exclusion: Clinical trials still fall short enrolling older adults - 8 months ago Endangered horseshoe crabs could lead the charge in pharma’s animal-free future - 8 months ago